rs1553356208

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The NM_152490.5(B3GALNT2):​c.10T>C​(p.Trp4Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00000075 in 1,333,858 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 7.5e-7 ( 0 hom. )

Consequence

B3GALNT2
NM_152490.5 missense

Scores

3
4
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.24

Publications

0 publications found
Variant links:
Genes affected
B3GALNT2 (HGNC:28596): (beta-1,3-N-acetylgalactosaminyltransferase 2) This gene encodes a member of the glycosyltransferase 31 family. The encoded protein synthesizes GalNAc:beta-1,3GlcNAc, a novel carbohydrate structure, on N- and O-glycans. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Mar 2013]
B3GALNT2 Gene-Disease associations (from GenCC):
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Genomics England PanelApp
  • autosomal recessive non-syndromic intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscle-eye-brain disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • intellectual disability
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
B3GALNT2NM_152490.5 linkc.10T>C p.Trp4Arg missense_variant Exon 1 of 12 ENST00000366600.8 NP_689703.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
B3GALNT2ENST00000366600.8 linkc.10T>C p.Trp4Arg missense_variant Exon 1 of 12 1 NM_152490.5 ENSP00000355559.3

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
7.50e-7
AC:
1
AN:
1333858
Hom.:
0
Cov.:
33
AF XY:
0.00000152
AC XY:
1
AN XY:
657918
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26806
American (AMR)
AF:
0.00
AC:
0
AN:
30642
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23312
East Asian (EAS)
AF:
0.00
AC:
0
AN:
28856
South Asian (SAS)
AF:
0.00
AC:
0
AN:
75566
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
32914
Middle Eastern (MID)
AF:
0.000237
AC:
1
AN:
4228
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1056206
Other (OTH)
AF:
0.00
AC:
0
AN:
55328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11 Uncertain:1
Jan 24, 2020
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with B3GALNT2-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces tryptophan with arginine at codon 4 of the B3GALNT2 protein (p.Trp4Arg). The tryptophan residue is weakly conserved and there is a moderate physicochemical difference between tryptophan and arginine. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.64
BayesDel_addAF
Uncertain
0.057
T
BayesDel_noAF
Benign
-0.16
CADD
Uncertain
24
DANN
Benign
0.97
DEOGEN2
Benign
0.051
T;.
Eigen
Uncertain
0.28
Eigen_PC
Uncertain
0.24
FATHMM_MKL
Benign
0.44
N
M_CAP
Pathogenic
0.87
D
MetaRNN
Uncertain
0.61
D;D
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
0.81
L;L
PhyloP100
4.2
PrimateAI
Pathogenic
0.92
D
PROVEAN
Benign
-1.6
N;N
REVEL
Benign
0.25
Sift
Benign
0.047
D;.
Sift4G
Benign
0.069
T;D
Polyphen
0.93
P;D
Vest4
0.44
MutPred
0.73
Gain of methylation at W4 (P = 0.0139);Gain of methylation at W4 (P = 0.0139);
MVP
0.57
MPC
0.75
ClinPred
0.71
D
GERP RS
3.2
PromoterAI
-0.032
Neutral
Varity_R
0.42
gMVP
0.68
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1553356208; hg19: chr1-235667543; API